Independent Review Committee

in page functions

Gavi has established an Independent Review Committee for the review of new proposals

To support an independent and systematic process of reviewing new proposals, Gavi has established an Independent Review Committee (IRC).

Key characteristics

Since its inception, the structure and composition of the Gavi IRC have been considered effective due to key characteristics:

  • the committee relies upon a wide range of experts in public health, epidemiology, development, finance and economics;
  • the committee is based on a system of peer review; and
  • the committee is independent.

The Gavi Board

The IRC is directly accountable to the Gavi Board and communicates its recommendations to the Gavi Board. The Gavi Board makes the ultimate decision on whether to approve the funding of new country grants. The Gavi Board also has the responsibility for communicating its decision to countries, via the Gavi Secretariat.

More on this topic

The Independent Review Committee reviews new proposals and makes recommendations to the Gavi Board

The mandate of the new proposals IRC is to review each application for all types of new support, to enable a more holistic view of the broad portfolio of support Gavi provides to countries, rather than looking at each new application in isolation from the others, and to make recommendations to the Gavi Board.

This review should consider the information available to countries within current guidelines and application forms and ensure that any new proposal contributes to achieving:

  • the Gavi mission - ‘To save children’s lives and protect people’s health by increasing access to immunisation in poor countries’;
  • the Gavi's strategic goals; and
  • the eligibility criteria as per Gavi guidelines for new proposals of support.

Members of the Independent Review Committee consist of specialists from a broad range of expertise

IRC members generally serve a term of three years. This term may be renewed for another period of up to 3 years. Upon reaching the second term limit IRC members will not be eligible to serve on the IRC for at least 1 year. During their term IRC members may be called upon to serve on the IRC for review of country plans or requests for extensions for which he or she has specific relevant skills.

Range of expertise

The increasing complexity of new proposals and the subsequent grant monitoring requires an IRC with a broad range of expertise in areas such as:

  • Routine immunisation programmes, especially at country level;
  • Management of campaigns;
  • Delivery of health services including child and adolescent health;
  • Health systems strengthening and management;
  • Epidemiology and disease control;
  • Cold chain and logistics;
  • Financial and budget analysis; and
  • Gender and equity.

The IRC should also consist of technical experts knowledgeable on the developing country context and relevant issues, including in a variety of fields related to immunisation and health systems, and who have practical experience working in or with developing country governments, civil society, and other partners in those contexts. In addition, the IRC should be geographically diverse, with a male and female representation consistent with Gavi’s Gender Policy and Guidelines on the Gavi Board Gender Balance.

Each IRC member is asked to sign a confidentiality and conflict of interest statement and will not come from Vaccine Alliance partner agencies, and have not taken part in technical assistance to or pre-review processes of country applications.

List of IRC pool members

Click here to view the biographies of the IRC members  

Nr

Name

Areas of expertise

Current position

1

Sam Agbo

Health systems management, immunisation programs, and civil society

Head of Health & HIV at Save the Children

2

Salah Al Awaidy

Vaccine-preventable diseases programming, immunisation and cold chain

Advisor at the Ministry of Health, Oman

3

Badel Al Rawani

Vaccines management and cold chain

Head of the Expanded Programme on Immunisation in the Department of Communicable Disease Surveillance and Control, Ministry of Health, Oman

4

Roland Georges Amehou

Health economics and financial and budget analysis

Health economist in developing countries

5

Rafah Salam Aziz

MNCH programme management, immunisation

Independent consultant

6

Gabriel Carrasquilla

Epidemiology

Founder and Director of ASIESALUD

7

John Clements

Routine immunisation services in developing countries

Independent consultant and Associate Professor in the School of Population Health, Faculty of Medicine and Dentistry, University of Melbourne, Honorary Associate Professor at Monash University

8

Ahmed Ali Darwish

Epidemiology and immunisation programs

Independent consultant

9

Jean Marie Edengue Ekani

Immunisation, health systems management, epidemiology

Immunisation specialist MoH, Cameroon

10

George Gotsadze

Health policy and systems, health care financing

Director of the Curatio International Foundation in Georgia. Professor of health care financing and health policy at the School of Public Health, Tbilisi State Medical University Georgia

11

John Grundy

Health systems strengthening and immunisation

Independent consultant

12

Terence Hart

Supply chain logistics and technologies

Independent consultant

13

Miloud Kaddar

Health economics, economics of vaccines and immunization, health system development and financing

Independent consultant

14

Elsie Le Franc

Health systems and health policy analysis

Professor Emeritus and Adjunct Professorial Research Fellow, University of the West Indies, Jamaica

15

Marina Madeo

Health systems strengthening, technical coordination, health sector governance

Independent consultant

16

Kapil Maithal

Conceptualizing, managing, strategizing and execution of development of vaccines for global use; vaccine advocacy and preparedness

General Manager and Head-Research and Development at Indian Immunologicals Limited (IIL), Hyderabad, India

17

Andrew McKenzie

Health systems strengthening, health planning and management

Independent consultant, Senior Partner in Health Partners International

18

Sandra Mounier-Jack

Health policy and health financing

Lecturer in Health Policy at the Faculty of Public Health and Policy of the London School of Hygiene and Tropical Medicine

19

Amani Mustafa

Immunisation, new vaccines, campaign management, cold chain and health system planning and monitoring. 

Public Health Training Initiative Project Manager, The Carter Center, Sudan. National Director of Planning, Monitoring, and Policy Directorate, National Medicines and Poisons Board, Sudan

20

Maryanne Neill

Health information systems, cold chain logistics, immunisation coverage estimation.

Independent consultant

21

Frank Nyonator

health systems and health service provision

Ag. Dean of the School of Public Health, University of Health and Allied Sciences (UHAS) Ghana, Head of the Health Policy, Planning and Management Department of the School

22

Bolanle Oyeledun

Health systems strengthening, MNCH, immunisation

Chief Executive Officer at Centre for Integrated Health Programs (CIHP), Nigeria

23

Koye Oyerinde

Paediatrics, Health Systems Strengthening

Attending paediatrician in private practice

24

Zeenat Patel

Public health, epidemiology, immunisation

Independent consultant

25

Arletty Pinel

Health systems strengthening,  maternal health

Independent consultant

26

Bob Pond

health systems strengthening with special emphasis on child health, disease control and HIS development

Independent consultant

27

Kshem Prasad

Evaluation of programme logistics, assessments of immunization supply chain and development of plans for system strengthening

Independent consultant  

28

Diana Rivington

Gender equality, human rights, children’s rights

Senior Fellow in the Faculty of Social Sciences at the University of Ottawa, Canada

29

Gayane Sahakyan

Epidemiology, immunisation services

National Immunisation Program Manager, Republic of Armenia

30

Malek Sbih

Cold chain and logistics

Independent consultant

31

Mario Stassen

Design of development strategies, risk management and patient safety

Lecturer at Faculty of Science, Department of Biopharmacy at University of Utrecht; Board member of the Edufarma Foundation

32

Ousmane Amadou Sy

Financial management systems for health

Independent consultant

33

Stephanie Tache

Healthcare systems strengthening, primary health care workforce organisation, medical care for marginalised populations

Independent Consultant

34

Michael Thiede

Health economics, health policy and health systems, procurement and logistics

Managing Director of the Scenarium Group GmbH

35

Asnakew Tsega

Public health, Epidemiology, program management, monitoring and evaluation

Immunisation senior technical officer at USAID funded Maternal and Child Survival Program (MCSP)

36

Charles Shey Umaru Wiysonge

Vaccinology, systematic reviews, programme management

Full Professor and Deputy Director in the Centre for Evidence-based Health Care, Stellenbosch University, South Africa 

37

Beena Varghese

Costing and evaluation of MNCH interventions; analysis of health system level issues in MNCH

Senior Health Economist at the Public Health Foundation of India (PHFI) and Adjunct Professor at the St. Johns Research Institute in Bangalore

38

Abdul Wali

Policy and strategy development, health information management, assessments, health system strengthening, immunization

Director of a leading Afghan NGO involved in research, monitoring and evaluation

39

Prashant Yadav

Supply chain management; cold chain logistics

Director of Healthcare Delivery Research at the University of Michigan’s William Davidson Institute and faculty member at the Ross School of Business and the School of Public Health at the University of Michigan

40

Shamsa Zafar

MNCH, Gender

Head of Department, Centre of Excellence in MNCH at the Health Services Academy, Pakistan

close icon

modal window here